Filing metadata

Accession number
0001209191-23-054525
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Nov 06, 2023
Reporting period
Nov 03, 2023
Description
Insider transaction

Explore SEC Filings Hub